Clinical and Immunological Profile of Mixed Connective Tissue Disease and a Comparison of Four Diagnostic Criteria
Authors:
Open Access
- 29 January 2020
- journal article
- research article
- Published by Wiley in International Journal of Rheumatology
- Vol. 2020, 1-6
Abstract
Mixed connective tissue disease (MCTD) was initially described as a chronic immune-mediated disease with overlapping features of systemic lupus erythematosus, scleroderma, and polymyositis. We conducted a cross-sectional study to describe the clinical and immunological profile of patients with MCTD and to compare the four diagnostic criteria, namely, Sharp, Kasukawa, Alarcón-Segovia, and Khan criteria. A total of 291 patients who were admitted from June 2007 to June 2017 and fulfilled the inclusion criteria were included in the study. A clinical diagnosis of MCTD was made in 111 patients, of whom 103 (92.8%) were women. The mean age at presentation was 39.3 years (). The most common organ systems that were involved were musculoskeletal system (95.5%), skin and mucosa (78.4%), and the gastrointestinal and hepatobiliary systems (56%). The maximum sensitivity was for the Kasukawa criteria with a sensitivity of 77.5% (95% CI 68.4-84.6) and specificity of 92.2% (95% CI 87-95.5). The Kahn criteria and Alarcón-Segovia criteria had the maximum specificity; the Alarcón-Segovia criteria had a sensitivity of 69.4% (95% CI 59.8-77.6) and a specificity of 99.4% (95% CI 96.5-99.9), while the Kahn criteria had a sensitivity of 52.3% (95% CI 42.6-61.7) and a specificity of 99.4% (95% CI 96.5-99.9). The sensitivity and specificity of Sharp criteria were 57.7% (95% CI 47.9-66.87) and 90% (95% CI 84.4-93.8), respectively.
Keywords
This publication has 20 references indexed in Scilit:
- Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literatureRheumatology, 2013
- “To Be or Not To Be,” Ten Years After: Evidence for Mixed Connective Tissue Disease as a Distinct EntitySeminars in Arthritis and Rheumatism, 2012
- The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patientsAnnals of the Rheumatic Diseases, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Clinical and Immunoserological Characteristics of Mixed Connective Tissue Disease Associated with Pulmonary Arterial HypertensionScandinavian Journal of Immunology, 2006
- Rheumatoid factor isotypes in mixed connective tissue diseaseClinical Rheumatology, 2006
- Pulmonary Vascular Manifestations of Mixed Connective Tissue DiseaseRheumatic Disease Clinics of North America, 2005
- COMPARISON BETWEEN 3 DIAGNOSTIC-CRITERIA FOR MIXED CONNECTIVE-TISSUE DISEASE - STUDY OF 593 PATIENTS1989
- Renal involvement in mixed connective tissue disease: A longitudinal clinicopathologic studySeminars in Arthritis and Rheumatism, 1986
- Mixed connective tissue disease: A clinicopathologic study of 20 casesSeminars in Arthritis and Rheumatism, 1980